Table 4.

Results of dual X–ray absorptiometry (DXA) measurements in studied groups.

	Vitamin D			Placebo
	No	Mean	CI (–95%)	No	Mean	CI (–95%)	p
Sp BMD visit 1	83	0.76 ± 0.18	0.72–0.80	67	0.74 ± 0.18	0.70–0.79	0.447
Sp BMD visit 4	47	0.82 ± 0.19	0.76–0.87	47	0.80 ± 0.19	0.75–0.86	0.623
Δ in Sp BMD visit 4–1	47	0.04 ± 0.04	0.03–0.06	47	0.06 ± 0.04	0.05–0.08	0.025 *
TBLH BMD visit 1	83	0.87 ± 0.14	0.84–0.90	67	0.86 ± 0.15	0.82–0.89	0.672
TBLH BMD visit 4	48	0.91 ± 0.14	0.87–0.95	47	0.90 ± 0.15	0.86–0.94	0.740
Δ in TBLH BMD visit 4–1	48	0.04± 0.03	0.04–0.05	47	0.04 ± 0.03	0.03–0.05	0.504*
TFM (kg) visit 1	83	25.18 ± 9.76	23.05–27.31	67	24.29 ± 9.08	22.08–26.51	0.652
TFM (kg) visit 4	48	25.17 ± 8.72	22.63–27.70	47	25.07 ± 8.96	22.44–27.70	0.959*
Δ in TFM visit 4–1	48	0.73 ±4.55	–0.59–2.05	47	0.68 ± 4.96	–0.77–2.14	0.734
TLM (kg) visit 1	83	32.52 ± 4.55	30.04–34.99	67	31.83 ± 10.94	29.16–34.50	0.823
TLM (kg) visit 4	48	34.41 ± 10.33	31.41–37.42	47	34.48 ± 12.19	30.90–38.06	0.976 *
TFM (%) visit 1	48	43.46 ± 3.82	42.35–44.57	47	43.30 ± 4.42	42.00–44.60	0.847
TFM (%) visit 4	48	41.89 ± 5.29	40.35–43.43	47	42.32 ± 5.50	40.71–43.94	0.695
Δ in TFM (%) visit 4–1	48	–1.57 ± 4.12	–2.77–0.38	47	–0.98 ± 3.97	–2.14–0.19	0.472 *
TLM (%) visit 1	48	56.54 ± 3.82	55.43–57.65	47	56.70 ± 4.42	55.40–58.00	0.847
TLM (%) visit 4	48	58.11 ± 5.29	56.57–59.65	47	57.68 ± 5.50	56.06–59.29	0.695
Δ in TLM (%) visit 4–1	48	1.57 ± 4.12	0.38–2.77	47	0.98 ± 3.97	–0.19–2.14	0.472

p < 0.05 Mann–Whitney U test, * t–student test for independent samples. Sp—spine, BMD—bone mineral density, Δ—delta–difference, TBLH—total body less head, TFM—total fat mass, TLM—total lean mass.